342 related articles for article (PubMed ID: 30455684)
1. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.
Jang YJ; Lim JY; Kim S; Lee Y; Kweon MN; Kim JH
Front Immunol; 2018; 9():2330. PubMed ID: 30455684
[TBL] [Abstract][Full Text] [Related]
2. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.
Kim HC; Lim JY; Kim S; Kim JH; Jang YJ
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3899-3906. PubMed ID: 28828551
[TBL] [Abstract][Full Text] [Related]
3. Altered Immune Regulation of Dendritic Cells and Enhanced Cytokine Production of T Cells in the Pathogenesis of Eosinophilic Chronic Rhinosinusitis.
Kawakami K; Miyasaka T; Ohno I; Ohta N; Masuda-Suzuki C; Tateda Y; Kusano Y; Shoji F; Kitaya S; Nakamura Y; Arikawa T; Kawano T; Takayanagi M; Takahashi T
Int Arch Allergy Immunol; 2021; 182(6):535-545. PubMed ID: 33494088
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity.
Tsuda T; Maeda Y; Nishide M; Koyama S; Hayama Y; Nojima S; Takamatsu H; Okuzaki D; Kinehara Y; Kato Y; Nakatani T; Obata S; Akazawa H; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
Int Immunol; 2019 Feb; 31(1):33-40. PubMed ID: 30239772
[TBL] [Abstract][Full Text] [Related]
5. γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps.
Li X; Wang Z; Chang L; Chen X; Yang L; Lai X; Li S; Huang J; Huang Z; Wu X; Bellanti JA; Zheng SG; Zhang G
Clin Sci (Lond); 2019 Nov; 133(22):2301-2315. PubMed ID: 31722010
[TBL] [Abstract][Full Text] [Related]
6. IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients.
Kubota K; Takeno S; Taruya T; Sasaki A; Ishino T; Hirakawa K
J Otolaryngol Head Neck Surg; 2017 May; 46(1):36. PubMed ID: 28464955
[TBL] [Abstract][Full Text] [Related]
7. A murine model of eosinophilic chronic rhinosinusitis using the topical application of a vitamin D3 analog.
Kagoya R; Kondo K; Kishimoto-Urata M; Shimizu Y; Kikuta S; Yamasoba T
Allergy; 2021 May; 76(5):1432-1442. PubMed ID: 33058214
[TBL] [Abstract][Full Text] [Related]
8. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
Kambara R; Minami T; Akazawa H; Tsuji F; Sasaki T; Inohara H; Horii A
Int Arch Allergy Immunol; 2017; 173(4):225-232. PubMed ID: 28848094
[TBL] [Abstract][Full Text] [Related]
9. Expression of heme oxygenase-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps: modulation by cytokines.
Yu Z; Wang Y; Zhang J; Li L; Wu X; Ma R; Han M; Xu G; Wen W; Li H
Int Forum Allergy Rhinol; 2015 Aug; 5(8):734-40. PubMed ID: 25907676
[TBL] [Abstract][Full Text] [Related]
10. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
[TBL] [Abstract][Full Text] [Related]
11. Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings.
Yun Y; Kanda A; Kobayashi Y; Van Bui D; Suzuki K; Sawada S; Baba K; Yagi M; Asako M; Okazaki H; Ikeda H; Kawamura S; Nakamura A; Dombrowicz D; Tomoda K; Iwai H
Allergol Int; 2020 Apr; 69(2):232-238. PubMed ID: 31928947
[TBL] [Abstract][Full Text] [Related]
12. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
Tsuda T; Nishide M; Maeda Y; Hayama Y; Koyama S; Nojima S; Takamatsu H; Okuzaki D; Morita T; Nakatani T; Kato Y; Nakanishi Y; Futami Y; Suga Y; Naito Y; Konaka H; Satoh S; Naito M; Izumi M; Obata S; Nakatani A; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
J Allergy Clin Immunol; 2020 Mar; 145(3):843-854.e4. PubMed ID: 32035658
[TBL] [Abstract][Full Text] [Related]
13. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
[TBL] [Abstract][Full Text] [Related]
14. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
15. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
Ma J; Shi LL; Deng YK; Wang H; Cao PP; Long XB; Zhang XH; Liu Y; Zeng M; Liu Z
Clin Exp Allergy; 2016 Sep; 46(9):1162-75. PubMed ID: 27176491
[TBL] [Abstract][Full Text] [Related]
16. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps.
Baba S; Kondo K; Kanaya K; Suzukawa K; Ushio M; Urata S; Asakage T; Kakigi A; Suzukawa M; Ohta K; Yamasoba T
Laryngoscope; 2014 Apr; 124(4):E115-22. PubMed ID: 24122812
[TBL] [Abstract][Full Text] [Related]
17. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.
Takabayashi T; Schleimer RP
J Allergy Clin Immunol; 2020 Mar; 145(3):740-750. PubMed ID: 32145873
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.
Wei H; Xu L; Sun P; Xing H; Zhu Z; Liu J
Int J Immunopathol Pharmacol; 2022; 36():3946320221109529. PubMed ID: 35726645
[TBL] [Abstract][Full Text] [Related]
19. IL-17A facilitates type 2 inflammation in a modified eosinophilic chronic rhinosinusitis mouse model.
Wu H; Wang Z; Li X; Chen X; Li Y; Huang W; Chang L; Zhang G
Int Forum Allergy Rhinol; 2023 Sep; 13(9):1726-1737. PubMed ID: 36716409
[TBL] [Abstract][Full Text] [Related]
20. High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis.
Ren X; Wang Z
Life Sci; 2021 Apr; 271():119218. PubMed ID: 33592198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
